nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—ORM1—saliva—nicotine dependence	0.0856	0.282	CbGeAlD
Nateglinide—Urine output increased—Varenicline—nicotine dependence	0.03	0.0628	CcSEcCtD
Nateglinide—Polyuria—Varenicline—nicotine dependence	0.0274	0.0574	CcSEcCtD
Nateglinide—Injury—Varenicline—nicotine dependence	0.0262	0.0549	CcSEcCtD
Nateglinide—Increased appetite—Varenicline—nicotine dependence	0.0256	0.0537	CcSEcCtD
Nateglinide—Thirst—Varenicline—nicotine dependence	0.0253	0.053	CcSEcCtD
Nateglinide—Hypoglycaemia—Varenicline—nicotine dependence	0.0247	0.0517	CcSEcCtD
Nateglinide—Osteoarthritis—Varenicline—nicotine dependence	0.0241	0.0504	CcSEcCtD
Nateglinide—KCNJ11—cardiovascular system—nicotine dependence	0.0229	0.0755	CbGeAlD
Nateglinide—ABCC8—cardiovascular system—nicotine dependence	0.0211	0.0695	CbGeAlD
Nateglinide—Bronchitis—Varenicline—nicotine dependence	0.02	0.0419	CcSEcCtD
Nateglinide—SLC16A1—cardiovascular system—nicotine dependence	0.0192	0.0633	CbGeAlD
Nateglinide—Hepatobiliary disease—Varenicline—nicotine dependence	0.0175	0.0368	CcSEcCtD
Nateglinide—ABCC8—midbrain—nicotine dependence	0.0165	0.0543	CbGeAlD
Nateglinide—Oedema peripheral—Varenicline—nicotine dependence	0.0164	0.0344	CcSEcCtD
Nateglinide—PPARG—cardiovascular system—nicotine dependence	0.0161	0.0531	CbGeAlD
Nateglinide—Erythema multiforme—Varenicline—nicotine dependence	0.0157	0.033	CcSEcCtD
Nateglinide—Immune system disorder—Varenicline—nicotine dependence	0.015	0.0315	CcSEcCtD
Nateglinide—SLC16A1—midbrain—nicotine dependence	0.015	0.0494	CbGeAlD
Nateglinide—Malnutrition—Varenicline—nicotine dependence	0.0145	0.0304	CcSEcCtD
Nateglinide—Back pain—Varenicline—nicotine dependence	0.014	0.0294	CcSEcCtD
Nateglinide—Tremor—Varenicline—nicotine dependence	0.0136	0.0285	CcSEcCtD
Nateglinide—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0131	0.0598	CbGpPWpGaD
Nateglinide—Palpitations—Varenicline—nicotine dependence	0.0128	0.0268	CcSEcCtD
Nateglinide—Cough—Varenicline—nicotine dependence	0.0127	0.0265	CcSEcCtD
Nateglinide—SLC22A6—brain—nicotine dependence	0.0119	0.0392	CbGeAlD
Nateglinide—Hyperhidrosis—Varenicline—nicotine dependence	0.0114	0.024	CcSEcCtD
Nateglinide—KCNJ11—brain—nicotine dependence	0.0113	0.037	CbGeAlD
Nateglinide—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0109	0.0496	CbGpPWpGaD
Nateglinide—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0108	0.0492	CbGpPWpGaD
Nateglinide—Dyspepsia—Varenicline—nicotine dependence	0.0104	0.0218	CcSEcCtD
Nateglinide—ABCC8—brain—nicotine dependence	0.0104	0.0341	CbGeAlD
Nateglinide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0102	0.0214	CcSEcCtD
Nateglinide—Fatigue—Varenicline—nicotine dependence	0.0102	0.0214	CcSEcCtD
Nateglinide—SLC15A2—midbrain—nicotine dependence	0.00986	0.0325	CbGeAlD
Nateglinide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00968	0.0203	CcSEcCtD
Nateglinide—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00946	0.0433	CbGpPWpGaD
Nateglinide—CYP2C9—cardiovascular system—nicotine dependence	0.00945	0.0311	CbGeAlD
Nateglinide—SLC16A1—brain—nicotine dependence	0.00944	0.031	CbGeAlD
Nateglinide—Urticaria—Varenicline—nicotine dependence	0.0094	0.0197	CcSEcCtD
Nateglinide—Abdominal pain—Varenicline—nicotine dependence	0.00936	0.0196	CcSEcCtD
Nateglinide—Hypersensitivity—Varenicline—nicotine dependence	0.00872	0.0183	CcSEcCtD
Nateglinide—PTGS1—cardiovascular system—nicotine dependence	0.00863	0.0284	CbGeAlD
Nateglinide—Asthenia—Varenicline—nicotine dependence	0.00849	0.0178	CcSEcCtD
Nateglinide—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00847	0.0387	CbGpPWpGaD
Nateglinide—Pruritus—Varenicline—nicotine dependence	0.00837	0.0175	CcSEcCtD
Nateglinide—Diarrhoea—Varenicline—nicotine dependence	0.0081	0.017	CcSEcCtD
Nateglinide—PPARG—brain—nicotine dependence	0.00792	0.026	CbGeAlD
Nateglinide—Dizziness—Varenicline—nicotine dependence	0.00783	0.0164	CcSEcCtD
Nateglinide—Vomiting—Varenicline—nicotine dependence	0.00752	0.0158	CcSEcCtD
Nateglinide—Rash—Varenicline—nicotine dependence	0.00746	0.0156	CcSEcCtD
Nateglinide—Dermatitis—Varenicline—nicotine dependence	0.00745	0.0156	CcSEcCtD
Nateglinide—ALB—brain—nicotine dependence	0.00743	0.0244	CbGeAlD
Nateglinide—ABCC4—brain—nicotine dependence	0.00719	0.0237	CbGeAlD
Nateglinide—Nausea—Varenicline—nicotine dependence	0.00703	0.0147	CcSEcCtD
Nateglinide—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00673	0.0308	CbGpPWpGaD
Nateglinide—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00667	0.0305	CbGpPWpGaD
Nateglinide—SLC15A2—brain—nicotine dependence	0.0062	0.0204	CbGeAlD
Nateglinide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00544	0.0248	CbGpPWpGaD
Nateglinide—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00536	0.0245	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNB3—nicotine dependence	0.00448	0.0205	CbGpPWpGaD
Nateglinide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00441	0.0201	CbGpPWpGaD
Nateglinide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0044	0.0201	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNB3—nicotine dependence	0.00434	0.0199	CbGpPWpGaD
Nateglinide—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00427	0.0195	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNA6—nicotine dependence	0.00424	0.0194	CbGpPWpGaD
Nateglinide—PTGS1—brain—nicotine dependence	0.00423	0.0139	CbGeAlD
Nateglinide—KCNJ11—Neuronal System—CHRNA6—nicotine dependence	0.00412	0.0188	CbGpPWpGaD
Nateglinide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00393	0.018	CbGpPWpGaD
Nateglinide—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00388	0.0177	CbGpPWpGaD
Nateglinide—CYP2D6—brain—nicotine dependence	0.00348	0.0114	CbGeAlD
Nateglinide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00319	0.0146	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—GABRA4—nicotine dependence	0.00307	0.014	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—GABRA4—nicotine dependence	0.00298	0.0136	CbGpPWpGaD
Nateglinide—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00295	0.0135	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNB4—nicotine dependence	0.00294	0.0135	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNB4—nicotine dependence	0.00285	0.013	CbGpPWpGaD
Nateglinide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00279	0.0128	CbGpPWpGaD
Nateglinide—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00278	0.0127	CbGpPWpGaD
Nateglinide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00277	0.0127	CbGpPWpGaD
Nateglinide—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00276	0.0126	CbGpPWpGaD
Nateglinide—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00274	0.0125	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNA5—nicotine dependence	0.00274	0.0125	CbGpPWpGaD
Nateglinide—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00273	0.0125	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNA5—nicotine dependence	0.00265	0.0121	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00248	0.0114	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00234	0.0107	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00231	0.0106	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00227	0.0104	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00226	0.0104	CbGpPWpGaD
Nateglinide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00225	0.0103	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNA3—nicotine dependence	0.00223	0.0102	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNA3—nicotine dependence	0.00216	0.00989	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNB2—nicotine dependence	0.00196	0.00898	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNB2—nicotine dependence	0.0019	0.0087	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00183	0.00836	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00183	0.00835	CbGpPWpGaD
Nateglinide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0018	0.00824	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00179	0.00821	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—CHRNA4—nicotine dependence	0.00178	0.00815	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—CHRNA4—nicotine dependence	0.00173	0.0079	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00169	0.00774	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00167	0.00763	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00165	0.00754	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00158	0.00721	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00149	0.00679	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00148	0.00677	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00138	0.0063	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—DRD2—nicotine dependence	0.00135	0.00618	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00128	0.00584	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00127	0.00578	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.0012	0.0055	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00119	0.00545	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00119	0.00542	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00118	0.00538	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00118	0.00538	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—CCAR1—nicotine dependence	0.00111	0.00505	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00102	0.00468	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000834	0.00382	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000787	0.0036	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000776	0.00355	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP2A7—nicotine dependence	0.000773	0.00353	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP2A7—nicotine dependence	0.000749	0.00343	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP2A7—nicotine dependence	0.000739	0.00338	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP2A7—nicotine dependence	0.000554	0.00253	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000532	0.00243	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000476	0.00218	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.0004	0.00183	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000388	0.00177	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000289	0.00132	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2A7—nicotine dependence	0.000249	0.00114	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000206	0.000941	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000204	0.000932	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000135	0.000615	CbGpPWpGaD
